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A therosclerosis, a chronic inflammatory disease of artery walls, originates as regions of local endothelial cell dysfunction characterized by enhanced permeability, inflammatory gene expression, and turnover. 1 Although classic risk factors for atherosclerosis, including hypercholesterolemia, hyperglycemia, and smoking occur throughout the vasculature, atherosclerotic plaques preferentially form at vessel curvatures, branch points, and bifurcations, where blood flow is of lower magnitude and exhibits complex features including turbulence, oscillations, separation, and reattachment, which we term disturbed flow. 2 Thus, flow patterns critically regulate the local susceptibility to atherosclerosis.
In vitro, laminar flow inhibits endothelial activation and turnover, whereas disturbed flow induces inflammatory signaling, enhanced turnover, and other features of atherosclerosis-susceptible regions of arteries. 3 Interestingly, laminar and disturbed flow both initially activate nuclear factor (NF)-B 4 and JNK (c-Jun N-terminal kinase), 5 intercellular adhesion molecule (ICAM)-1 expression, 6 and enhanced permeability. 7 However, in laminar flow, these events decrease at later times as the cells align in the direction of flow, whereas in disturbed flow, these events remain elevated. 3 Thus, the inability of cells to adapt to disturbed flow may mediate the differential cellular responses to these 2 flow patterns.
Integrins mediate an important subset of the endothelial response to flow. Shear stress stimulates integrin activation, 8, 9 conversion from a low affinity to a high affinity state, which triggers new integrin-matrix binding; integrins thereby regulate both flow-induced endothelial cell alignment and proinflammatory gene expression. 10 Individual integrin heterodimers differ in both their ligand preferences and signaling responses, allowing cells to differentiate between matrix substrates. Endothelial cells are normally on a basement membrane comprised mainly of laminins, collagen, and other glycoproteins. In contrast, during inflammation, angiogenesis or wound healing, provisional matrix proteins such as fibronectin and fibrinogen are deposited beneath the endothelium. 11 In in vitro flow models, flow-induced proinflammatory signaling (NF-B), 11 proinflammatory gene expression, 11 and endothelial permeability 7 are highly activated in endothelial cells on fibronectin or fibrinogen but not in cells on basement membrane proteins. Indeed, these pathways are actively suppressed in cells on collagen. In vivo, fibronectin is deposited beneath the endothelium at atherosclerosis-prone regions of arteries. Thus, matrix remodeling may play a critical role in atherogenesis.
The p21-activated kinase (PAK) family of Ser/Thr kinases regulate cell growth, migration, cytoskeletal organization and gene expression. 12 Shear stress stimulates PAK activation in cells on fibronectin but not in cells on basement membrane proteins or collagen, 7 and PAK mediates matrix-specific activation of the proinflammatory transcription factor NF-B, 13, 14 inflammatory gene expression, 13 and increased endothelial permeability 7 by flow. PAK is activated in atheroprone regions in vivo, which correlates with areas of fibronectin deposition and inflammatory gene expression. 7 However, the mechanisms mediating matrix-specific PAK activation remain unknown.
PAK is activated by the small GTPases Rac and Cdc42, 12 and suppressed by PAK inhibitory proteins (eg, nischarin, hPIP1), 15, 16 by dephosphorylation by phosphatases (PP2A, POPX1/2), 17, 18 and by phosphorylation by protein kinase (PK)A. 19 We therefore set out to elucidate the mechanism of differential PAK activation on different matrix proteins. Our results identify PKA as the critical mediator of matrixspecific PAK activation and hence proinflammatory signaling through NF-B.
Methods
Briefly, bovine aortic endothelial cells (BAECs) and human aortic endothelial cells (HAECs) on glass slides coated with specific matrix proteins were exposed to laminar or oscillatory flow using parallel plate flow chambers. Rac activation was assayed by affinity pulldown using GST-PBD (glutathione S-transferase-p21-binding domain). Rac and Cdc42 were inhibited with dominant negative Figure 1 . Analysis of the PAK upstream pathway. A, BAECs on fibronectin were treated with fibronectinblocking (16G3, 50 g/mL) or nonblocking (11E5, 50 g/mL) antibodies for 30 minutes. Cells were sheared for 15 minutes and PAK phosphorylation was determined by Western blotting for phospho-Ser141. Results are normalized to total protein (nϭ3). B, ECs expressing N17-Rac or N17-Cdc42 plated on a fibronectin matrix were sheared for 15 minutes. PAK activation was determined as described (nϭ3 to 5). C, ECs plated on collagen (Coll), Matrigel (MG), or fibronectin (FN) were sheared for the indicated times, and Rac activity was determined by affinity pull-down assays. Rac levels in the pull-down at the 0 and 15 minute time points were normalized to total Rac levels in whole cell lysates (nϭ4 to 6). **PϽ0.01; ***PϽ0.001 by multiple comparisons ANOVA. N17-Rac and N17-Cdc42 transfected using Lipofectamine 2000. PKA activation was determined by cAMP quantification, an in vitro kinase assay, and an affinity pull-down approach using GST-PKA inhibitor (PKI). 20 PAK activation was measured by Western blotting using an antibody to phospho-Ser141. NF-B activation was measured by phosphorylation of the p65 subunit and by p65 nuclear translocation. ICAM-1 expression was measured by Western blotting and quantitative real time PCR. In vivo studies were carried out using either 10-week-old or 36-to 38-week-old male C57Bl/6J mice in which the effects of PKA activation or inhibition on PAK phosphorylation and inflammatory gene expression was determined. An expanded Methods section is available in the Online Data Supplement at http://circres.ahajournals.org.
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Results
Regulation of PAK Activators
To determine the mechanism of matrix-specific PAK activation, we first investigated the upstream pathway by which shear stress activates PAK in endothelial cells (ECs) on fibronectin. Shear stress stimulates integrins, leading to activation of Rac and Cdc42, both of which can activate PAK. 10, 21 To determine whether flow-induced activation of PAK requires new integrin ligation, we pretreated ECs on fibronectin with either the fibronectin blocking (16G3) or a control nonblocking anti-fibronectin antibody (11E5) for 30 minutes. This short-term treatment does not significantly disrupt preexisting adhesions or induce cell rounding. 10, 21 Pretreatment with 16G3 but not 11E5 significantly inhibited flow-induced PAK activation ( Figure 1A ), indicating that shear stress stimulates PAK through integrin ligation.
To address the requirement for Rac and Cdc42, ECs on fibronectin were transfected with dominant negative N17-Rac or N17-Cdc42. Transfection efficiencies were Ϸ70% to 80% (Online Figure I) , which allowed biochemical analysis of the entire cell population. Only N17-Rac prevented flow-induced PAK activation ( Figure 1B ), indicating that Rac is the critical small GTPase in this pathway. To determine whether shear stress-induced Rac activation is matrix-specific, we plated ECs on collagen I, fibronectin, or diluted basement membrane protein (Matrigel), which, under these conditions, coats the slides similarly to fibronectin without forming a gel. 5, 7 After 4 hours, cells formed a confluent monolayer, at which time they were sheared for 15 or 30 minutes. Surprisingly, flow activated Rac equally well on basement membrane protein and fibronectin ( Figure 1C) . Thus, the pathway upstream of PAK is matrix-independent, consistent with previous data that flow-induced reactive oxygen species production, 13 which is thought to be regulated by Rac, 22 also occurs independently of matrix composition.
Flow-Induced PKA Activation Is Matrix-Dependent
We next investigated possible PAK inhibitory pathways. PKA can directly phosphorylate and suppress PAK 19 and has known antiinflammatory effects. 23, 24 To investigate this pathway, cells on Matrigel or fibronectin were sheared and cAMP was assessed. Flow stimulated a transient increase in cAMP in cells on Matrigel but not on fibronectin ( Figure 2A ). We next assayed PKA using an in vitro kinase assay (verified BAECs plated on Matrigel (MG) or fibronectin (FN)-coated slides were exposed to onset of laminar flow for the indicated times. A, cAMP concentration was determined by competitive ELISA assay and normalized to total protein (nϭ4 to 6). B, Kinase activity in PKA immunoprecipitates was determined in a kinase assay using GST-CREB as substrate and antibodies specific for phosphorylated CREB. Results at the 0 and 15 minute time points were normalized to PKA levels in the immunoprecipitates and for total CREB (nϭ3). C, PKA activity was determined by affinity pull-down using GST-PKI. Active PKA in the pulldowns was normalized to total PKA in cell lysates using the 0-and 15-minute time points (nϭ3). D, ECs plated on slides coated with collagen I (Coll I), collagen IV (Coll IV), laminin (LN), or fibrinogen (FG) were sheared for 15 minutes, and PKA activity was determined by GST-PKI pull-down (nϭ3 to 5). *PϽ0.05, **PϽ0.01, ***PϽ0.001 by multiple comparisons ANOVA.
using the PKA activator Br-cAMP and the PKA inhibitory peptide PKI; Online Figure II) . PKA activity increased Ͼ2.5-fold in cells on Matrigel but showed no change on fibronectin ( Figure 2B ). An affinity pull-down assay with the PKA pseudosubstrate PKI also showed an increase in ECs on Matrigel but not on fibronectin ( Figure 2C ). Thus, flow stimulates cAMP and PKA on basement membrane protein but not on fibronectin.
Matrigel contains several matrix proteins as well as growth factors. We therefore assayed PKA activity in ECs on purified basement membrane proteins (collagen I, collagen IV, laminin). We also examined the provisional matrix protein fibrinogen, which is deposited into the subendothelial matrix in wounds and at early stages of atherosclerosis. 11 In ECs on collagen I or collagen IV, PKA activation increased Ϸ2-fold after flow ( Figure 2D ), whereas cells on laminin showed no change and in cells on fibrinogen, PKA signaling decreased. These results suggest that collagens are the main component of Matrigel that promote PKA activation in response to flow.
PKA Regulates PAK Activation
We next tested if basement membrane-associated PKA signaling prevents flow-induced PAK activation. ECs on Matrigel were treated with membrane-permeable PKA inhibitory peptide (myristoylated PKI 14 -22 ) for 15 minutes, and PAK activation was determined. PKI rescued flow-induced PAK activation on Matrigel ( Figure 3A ) to near levels in cells on fibronectin ( Figure 1A ). Small interfering RNA against the PKA C␣ catalytic subunit (Ϸ70% knockdown; Online Figure  III ) similarly restored flow-induced PAK activation in cells on Matrigel ( Figure 3B ). These results show that PKA activation suppresses PAK on basement membranes.
Effects on Inflammatory Signaling
Low PAK activity mediates the inhibition of flow-induced NF-B activation and inflammatory gene expression in ECs on basement membrane proteins. 11, 13 We therefore investigated whether PKA suppresses flow-induced NF-B activation through PAK inhibition. When ECs on Matrigel were treated with PKI flow-induced NF-B activation was restored as indicated by nuclear translocation ( Figure 3C ; Online Figure IV ) and phosphorylation of p65 on Ser536 ( Figure  3D ). Rescue of NF-B in PKI-treated cells was blocked by a cell-permeant PAK inhibitory peptide (PNP) ( Figure 3C and 3D), 13, 25 indicating PAK was involved. Additionally, expression of the NF-B-dependent gene ICAM-1 in HAECs on Matrigel showed similar dependence on PAK and PKA ( Figure 3E ). Taken together, these results indicate that PKA activation in cells on Matrigel suppresses NF-B by inhibiting PAK. Figure 1 (nϭ3) . B, ECs transfected with small interfering RNA (siRNA) against the PKC C␣ catalytic subunit (Ϸ70% knockdown) were plated on Matrigel and sheared for 15 minutes. PAK was assayed as above (nϭ3). C and D, ECs plated on Matrigel were treated with PKI (20 mol/L for 15 minutes), the PAK inhibitory peptide (PNP; 20 g/mL for 60 minutes), or both. Cells were then sheared for 30 minutes and NF-B nuclear translocation (C) and phosphorylation on Ser536 (D) were determined. Western blots were normalized to total protein, and representative blots are shown (nϭ3). For nuclear translocation, Ͼ100 cells were counted for each condition and scored as positive or negative for nuclear NF-B. NF-B nuclear translocation was averaged from 3 independent experiments. E, HAECs plated on Matrigel were treated with PKI (20 mol/L for 15 minutes), the PAK inhibitory peptide PNP (20 g/mL for 60 minutes) or both and then sheared for 3 hours. ICAM-1 mRNA expression was determined using quantitative real-time PCR and normalized to ␤2-microglobulin mRNA. **PϽ0.01, ***PϽ0.001 by multiple comparisons ANOVA.
To further test this idea, ECs on fibronectin were treated with forskolin, a direct activator of adenylate cyclase, 26 or iloprost, a prostacyclin analog that stimulates the G␣s-dependent activation of adenylate cyclase. 27 Both agents blocked flow-induced PAK activation on fibronectin ( Figure  4A ). These agents may also stimulate signaling through the Epac/Rap1 pathway; however, the Epac activating compound 8-pCPT-2Ј-O-Me-cAMP did not inhibit PAK activation on fibronectin (Online Figure V) , implicating PKA as the primary regulator. Furthermore, pretreatment with iloprost also inhibited flow-induced NF-B phosphorylation ( Figure 4B 
PKA in Oscillatory Flow
To investigate whether the matrix-specific events observed with onset of laminar shear apply to disturbed flow, ECs were exposed to oscillatory flow (Ϯ5 dyn/cm 2 ) for 18 hours. Assays for PAK, NF-B, and PKA activation showed enhanced PAK and NF-B activity on fibronectin compared to Matrigel ( Figure 5A through 5C ). In contrast, oscillatory flow increased PKA activity Ϸ2-fold in cells on Matrigel compared to fibronectin ( Figure 5D ).
We next asked whether Matrigel-associated PKA activation also mediates suppression of PAK activation and NF-B-dependent gene expression. ECs were transfected with mCherry-tagged PKI, then plated on Matrigel and exposed to oscillatory flow for 18 hours. Despite 40% to 50% transfection efficiencies, PKI significantly increased PAK activation in oscillatory flow compared to control vector ( Figure 6A ). Additionally, HAECs on fibronectin were sheared in the presence of the phosphodiesterase (PDE) inhibitor isobutylmethylxanthine (IBMX) to stimulate cAMP accumulation Figure 1 (nϭ3 to 6) . B and C, ECs plated on fibronectin were treated with iloprost (1 mol/L for 30 minutes) and sheared for 30 minutes, and NF-B phosphorylation on Ser536 (B) and nuclear translocation (C) were determined as in Figure 3 (nϭ3) . *PϽ0.05, ***PϽ0.001 by multiple comparisons ANOVA. NF-B (A and B) were determined by Western blotting with phospho-specific antibodies as previously described (nϭ3 to 4). C, Cells were fixed and NF-B nuclear translocation was determined as in previous figures. Representative images are shown (nϭ3). D, PKA activity was determined using the GST-PKI affinity beads. Active PKA in the pull-down was normalized to total PKA in the lysate (nϭ3). Statistical method was Student's t test.
and PKA activation. Forskolin and iloprost were not used in these experiments because of the amounts required to reach the target concentration in the large volume of flow medium. IMBX (100 mol/L) completely inhibited PAK activation ( Figure 6B ), NF-B phosphorylation ( Figure 6C ), and ICAM-1 expression ( Figure 6D ) by oscillatory flow. Constitutively active PAK (T423E) restored NF-B activation ( Figure 6E ) and ICAM-1 expression ( Figure 6F ) by oscillatory flow in the presence of IBMX. Taken together, these data show that, similar to onset of laminar shear, basement membrane protein suppresses inflammatory activation of ECs by oscillatory flow via PKA activation and PKA-dependent PAK inhibition.
Activating PKA Limits PAK Activation In Vivo
Prostacyclin analogs, such as iloprost, reduce inflammatory gene expression and vascular permeability both in vitro and in vivo. 28, 29 We therefore assessed whether iloprost mediates some of its protective effects through PAK inhibition using aged C57Bl/6J mice that show a modest level of chronic inflammation in regions of disturbed flow (eg, the carotid sinus). Male C57Bl/6J mice (chow diet; 36 to 38 weeks old) received intraperitoneal injections of iloprost (20 g; Ϸ1 mg/kg). At 2.5 or 24 hours after injection, control mice showed PAK phosphorylation in the EC layer at the atheroprone carotid sinus, concomitant with ICAM-1 and vascular cell adhesion molecule (VCAM)-1 expression ( Figure 7A ). In contrast, mice treated with iloprost for 2.5 hours show a significant reduction in PAK activation ( Figure 7B ) as well as ICAM-1 ( Figure 7C ) and VCAM-1 ( Figure 7D ) expression. PAK activity and ICAM-1 expression remained lower at 24 hours after treatment; however, this effect did not reach statistical significance, mostly likely because iloprost has a short half Figure 6 . PAK mediates antiinflammatory PKA signaling in oscillatory flow. A, BAECs transfected (50% efficiency) with control, empty mCherry vector, or mCherry-PKI were plated on Matrigel and exposed to oscillatory flow for 18 hours. PAK activation was determined as in Figure 1 (nϭ4) . B, HAECs plated on fibronectin were exposed to oscillatory flow for 18 hours in the presence of the PDE inhibitor IBMX (100 mol/L) or vehicle control. B and C, PAK phosphorylation (B) and NF-B (C) phosphorylation were determined. D, ICAM-1 expression was determined by Western blotting and normalized to total protein (nϭ3). E and F, HAECs transfected with Myc-tagged T423E-PAK or control vector were plated on fibronectin and exposed to oscillatory flow in the presence of IBMX (100 mol/L) for 18 hours. NF-B phosphorylation (E) and ICAM-1 expression (F) were determined by Western blotting as previously described (nϭ3). *PϽ0.05, **PϽ0.01 by multiple comparisons ANOVA.
life in vivo. 30 Thus, activation of PKA can suppress PAK activation in atheroprone regions of arteries in vivo.
Because the effects of iloprost may result from secondary hemodynamic alterations, we also tested whether PKA inhibition could stimulate PAK activation and inflammation in otherwise healthy mice. Male C57Bl/6J mice (chow diet; 10 weeks old) were given retroorbital injections of PKI (24 g, Ϸ1.2 mg/kg) with or without the PAK inhibitory peptide (PNP; 50 g, Ϸ2.5 mg/kg). After 2.5 hours, PKI treatment significantly increased PAK activation within the carotid sinus compared to control mice along with ICAM-1 and VCAM-1 staining (Figure 8 ). PNP did not significantly affect PAK activation, consistent with previous reports that it inhibits downstream PAK signaling but not PAK activation directly, but it significantly reversed the effects of PKI on ICAM-1 ( Figure 8C ) and VCAM-1 ( Figure 8D ). Taken together, these results suggest that PKA signaling limits inflammation at least in part through PAK inhibition.
Discussion
Previous work showed that PAK is activated by flow in cells on fibronectin but not collagen or basement membrane protein, and that it subsequently regulates EC inflammatory gene expression and endothelial monolayer permeability. 5, 7, 13, 31, 32 We now show, first, that PAK activation by flow is matrix-specific despite equivalent activation of its direct upstream element Rac, suggesting that basement membranes actively suppress PAK. PKA was identified as the critical suppressor of PAK in this system, based on the matrix-specific cAMP production and PKA activation, the restoration of PAK activation in cells on basement membranes by inhibitors of PKA, and the suppression of PAK in cells on fibronectin by activators of PKA. Collagen appears to be the active component of the basement membrane. Furthermore, we show that PKA controls matrix-specific activation of NF-B and downstream genes through PAK. Lastly, we show that pharmacological activation of PKA inhibits PAK activation at sites of disturbed flow in vivo. Taken together, these data demonstrate that basement membrane proteins inhibit PAK and downstream inflammatory signaling through PKA. These results further suggest that PAK inhibition may mediate a subset of the antiinflammatory and barrier protective properties ascribed to PKA activators. 24, 28, 29 Although PKA has long been associated with the EC responses to flow, 33 the molecular mechanism of activation is unknown. PKA is classically activated through G␣s-dependent activation of adenylate cyclase. Although flow was reported to activate EC G protein-coupled receptors 34 and G proteins, 35 this work implicated G␣i and G␣q subclasses, not G␣s. Furthermore, these G protein-dependent signals affected the early calcium-dependent NO production, 36 but not the late calcium-independent NO production mediated by PKA. Ligation of the collagen-binding integrin ␣2␤1 by the perlecan fragment endorepellin stimulates PKA, 37 and direct application of mechanical force to ␤1 integrins can stimulate G␣s-dependent cAMP production and PKA activation. 38 However, there is currently no information about how integrins affect G␣s signaling.
Recently, PKA signaling was implicated in flow-induced EC alignment in cells plated on the connecting segment-1 fragment of fibronectin, a ligand for integrin ␣4␤1. 39 Flowinduced ␣4␤1 ligation induced polarized PKA activation, which was required for flow-induced EC alignment. 39 However, ECs express high levels of the integrin ␣5␤1, which is the endothelial fibronectin receptor in cells from multiple vascular beds, 40, 41 whereas expression of ␣4␤1 is less abundant and restricted to a small subset of ECs in vivo. 42 One potential implication of ␣4␤1-dependent PKA activation is that ␣4␤1 may serve as a protective signaling pathway limiting EC dysfunction induced by the ␣5␤1-fibronectin interaction. In support of this idea, fibronectin stimulated the ␣5␤1-dependent expression of NF-B target gene MMP-9 in fibroblasts, which was diminished by ␣4␤1 expression. 43 The molecular mechanism by which PKA inhibits PAK activation is currently unknown. Previous work suggested that PKA phosphorylates PAK directly, 19 although at an unknown site. Alternatively, PKA could mediate PAK suppression indirectly through activation of endothelial NO synthase and PKG, which similarly phosphorylates PAK directly. 44 PKA-dependent PAK suppression could also result from regulation of protein phosphatases. PP2A dephosphorylates PAK, limiting its activation, 18 and PKA can directly stimulate PP2A phosphatase activity. 45 Future work will be required to determine the mechanism by which PKA inhibits PAK.
Multiple stimuli, including prostacyclin and adiponectin, reduce endothelial permeability through PKA signaling. 24, 28, 46 Proposed mechanisms for PKA-dependent barrier protection include inhibition of Rho 47 and activation of Rac. 28 Active PAK destabilizes EC cell-cell junctions by enhancing cortical actin contractility 32 and stimulating vascular endothelial (VE) cadherin internalization, 31 and PAK inhibitors reduce endothelial permeability in vitro 7, 32 and in vivo. 7, 48 Thus, PKA-dependent PAK inhibition may mediate, at least in part, the barrier protective effects of PKA.
PAK signaling is classically associated with cell proliferation and migration. 12 As such, previous work has established PAK as a key regulator of vascular remodeling during development, 49 angiogenesis, 25 and restenosis. 50 Our work was the first to demonstrate a role for PAK signaling in EC inflammatory activation in atherogenesis. However, the therapeutic potential of long-term PAK inhibition is uncertain. Global PAK inhibitors are likely to induce deleterious side effects; a peptide inhibitor of PAK caused Alzheimer-like symptoms in mice, presumably because of inhibition of PAK3 in neuronal tissue. 51 As an alternative approach, identifying endogenous inhibitory pathways, such as PKA, may provide a more selective reduction of PAK activation under defined circumstances. The PDE inhibitor IBMX blocks PAK activation and inflammatory gene expression by oscillatory flow, and PDE4 inhibitors are currently in clinical trials as immunosuppressive agents used to treat asthma and chronic obstructive pulmonary disease. 52 However, global PKA activation may also produce deleterious side effects, and identifying endothelial cell-specific molecular targets (eg, adenylate cyclase isoforms, PDEs, A kinase anchoring proteins) will likely be required for efficient therapeutic intervention. PKA has been found to inhibit NF-B in other systems through unknown mechanisms; the present work therefore suggests that inhibition of PAK could play a wider role in this effect.
